Technology and Analysis.

A medication is likely to enter medical trials in 2011. Targeted forms of tumor therapy have obtained significant interest because the late 1990s. They employ small molecules that inhibit mutated, overexpressed, or critical proteins characteristic of a particular cancer cell Continue reading Technology and Analysis.